RHY

0.00%

6.1¢ rhythm biosciences limited

Xmas 2023 share price predicition, page-22

First 22 Last

Share
Profile

Follow
josiejow37

280 Posts.

95

23/02/23

20:30

Post #: 66430882
Share

Originally posted by scottpeterson: ↑

Let's go back to the start of this thread...

1) I make a prediction on a previous thread and give my reason why I think 90c is a target (due to interest rate rises). The timing was wrong but I didn't set the timing, the original thread poster said "xmas". I concede that it didn't happen before Christmas but at the time the share price was $1.40 and it has only drifted down ever since. I am wrong but I am a lot less wrong than everyone else on that thread. Moreover, I gave the reason why the price would go down and it wasn't due to anything RHY management had or had not done. It was just macroeconomics.
2) Since then, there is a lot of excitement on hotcopper about "TGA approval is imminent", this has gone on since September I think? This includes lots of talk about "255 days". There are entire threads about "255 days" and lots of circle jerks meanwhile the price drifts lower.
3) I post gloating about my ability to see prices of speculative stocks (e.g. RHY) going down as interest rates go up (shocking I know)
4) I present a new forecast of the price going lower as interest rates go up. But, I am bullish once TGA approval goes through in May/June. This is not inconsistent with the "255 day" pumpers. I am less bullish than some because TGA approval does not equal medicare subsidies.
5) "josiejow37' says "haven't you heard of 255 day max" and says "haven't you done any research?"
6) I spend 10min reading the TGA regulations and find there is no recourse for the 255 day thesis and state I think it's a load of s*it that won't be enforced
7) ShmoShady correctly infers I'm not a lawyer and starts questioning my legal knowledge. Meanwhile he doesn't state any of his legal qualifications and only puts up one article from 2010 whereby there was actual loss (not theoretical loss as would be the RHY case post 255 days).
8) I ask ShmoShady what his thesis is and he deflects and won't give his price target or what it is based on

Expand

Hi @scottpeterson

Fair point to consider the reliability of the TGA. Fortunately, they have an excellent track record -

Source document - https://www.tga.gov.au/sites/default/files/2022-11/performance-report-2021-22.docx

The 2020/21 Report was also 100% for meeting the 255 day timeframe.

Last edited by josiejow37: 23/02/23

RHY Price at posting: 94.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

VMM

Virdis Mining flags breakthrough with 76% neodymium and praseodymium recoveries

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

There are more pages in this discussion • 3 more messages in this thread...

First 22 Last

Add RHY (ASX) to my watchlist

(20min delay)
Last 6.1¢		Change 0.000(0.00%)		Mkt cap ! $15.16M

Open	High	Low	Value	Volume
6.1¢	6.1¢	6.1¢	$1.429K	23.42K

Buyers (Bids)

No.	Vol.	Price($)
1	25209	6.1¢

Sellers (Offers)

Price($)	Vol.	No.
6.4¢	10150	2

View Market Depth

No.	Vol.	Price($)
1	25221	0.061
2	124000	0.060
2	76000	0.059
4	268924	0.058
2	22855	0.056

Price($)	Vol.	No.
0.064	10150	2
0.065	49892	2
0.066	79998	1
0.070	415394	3
0.071	150525	1

Last trade - 13.28pm 17/07/2024 (20 minute delay)

RHY (ASX) Chart

Xmas 2023 share price predicition, page-22

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Virdis Mining flags breakthrough with 76% neodymium and praseodymium recoveries

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Xmas 2023 share price predicition, page-22

Top Stories

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Virdis Mining flags breakthrough with 76% neodymium and praseodymium recoveries

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News